Here, we investigated whether clinically relevant doses (15, 30, and 120 mg/kg/day) of cimetidine inhibit the hepatic activity of ALAS and HO in vivo, first in wildtype mice and then in a well-established genetic mouse model for AIP [26,33,34,35]. This evidence concerns the gene HMOX1 and autoimmune pancreatitis.